Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea flag South Korea · Delayed Price · Currency is KRW
113,300
+100 (0.09%)
At close: Apr 2, 2025, 3:30 PM KST

Daewoong Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
24,735121,73942,24024,50612,753
Upgrade
Depreciation & Amortization
48,97843,79739,69540,88340,882
Upgrade
Loss (Gain) From Sale of Assets
465.97-30,198-246.41,029-7,530
Upgrade
Asset Writedown & Restructuring Costs
15,4922,3725,2192,1098,103
Upgrade
Loss (Gain) From Sale of Investments
24,951-130.674,112-8,308-2,622
Upgrade
Loss (Gain) on Equity Investments
23,1531,443374.54-257.52355.37
Upgrade
Stock-Based Compensation
545.311,6181,8412,0051,195
Upgrade
Provision & Write-off of Bad Debts
2,1925,8352,2502,1253,596
Upgrade
Other Operating Activities
-6,22610,254-8,8525,81320,263
Upgrade
Change in Accounts Receivable
-22,597-478.7-23,193-20,69244,176
Upgrade
Change in Accounts Payable
-16,67416,59712,408-8,3731,865
Upgrade
Change in Other Net Operating Assets
-43,523-36,83842,368-844.34-22,056
Upgrade
Operating Cash Flow
51,492136,009118,21539,994100,981
Upgrade
Operating Cash Flow Growth
-62.14%15.05%195.58%-60.39%75.31%
Upgrade
Capital Expenditures
-155,145-109,338-65,227-29,088-26,486
Upgrade
Sale of Property, Plant & Equipment
43.051,446483.47257.4317,700
Upgrade
Cash Acquisitions
--5,807---
Upgrade
Divestitures
-45.59---
Upgrade
Sale (Purchase) of Intangibles
-73,858-46,289-46,826-45,633-30,781
Upgrade
Investment in Securities
-35,557-8,7916,983-13,220-87,584
Upgrade
Other Investing Activities
-636.343,12367.5--0
Upgrade
Investing Cash Flow
-265,451-165,621-106,872-87,683-127,152
Upgrade
Short-Term Debt Issued
80,000113,74286,15452,35252,087
Upgrade
Long-Term Debt Issued
325,18765,000149,683108,35791,561
Upgrade
Total Debt Issued
405,187178,742235,837160,709143,647
Upgrade
Short-Term Debt Repaid
-106,264-87,934-1,212-53,258-4,357
Upgrade
Long-Term Debt Repaid
-92,263-94,201-201,593-91,675-91,702
Upgrade
Total Debt Repaid
-198,527-182,136-202,805-144,933-96,059
Upgrade
Net Debt Issued (Repaid)
206,660-3,39433,03215,77647,588
Upgrade
Issuance of Common Stock
-49,890-40,24929,987
Upgrade
Dividends Paid
-7,741-7,278-8,066-6,458-6,193
Upgrade
Other Financing Activities
1,702-0-9,450656.41-4,796
Upgrade
Financing Cash Flow
200,62139,21815,51750,22466,587
Upgrade
Foreign Exchange Rate Adjustments
4,782-1,052184.471,073-211.65
Upgrade
Miscellaneous Cash Flow Adjustments
0-0---
Upgrade
Net Cash Flow
-8,5568,55527,0443,60840,205
Upgrade
Free Cash Flow
-103,65326,67152,98810,90674,495
Upgrade
Free Cash Flow Growth
--49.67%385.84%-85.36%111.12%
Upgrade
Free Cash Flow Margin
-7.29%1.94%4.14%0.95%7.06%
Upgrade
Free Cash Flow Per Share
-9008.372334.474786.97991.086986.64
Upgrade
Cash Interest Paid
23,08416,60411,4809,83910,667
Upgrade
Cash Income Tax Paid
38,9018,3919,0505,5002,906
Upgrade
Levered Free Cash Flow
-174,677-18,388-44,86444,98250,247
Upgrade
Unlevered Free Cash Flow
-170,311-9,886-39,61051,38756,878
Upgrade
Change in Net Working Capital
81,246-25,99127,360-29,462-62,231
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.